Incyte Corporation
USD114.66
+0.91 (+0.80%)
CEO
William J. Meury
IPO Date
1993-11-04
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$113.99
Prev. Close
$113.75
Day Low
$112.89
Day High
$115.48
52W Low
$66.83
52W High
$115.56
Market Cap
$22.91B
Volume
1.40M
| 1,642 |
| $0.00 |
| 10 Jun 2026 | BAKER BROS. ADVISORS LP | director, 10 percent owner: | A-Award | Acquired | 6,111 | $100.64 |
| 10 Jun 2026 | HARRIGAN EDMUND | director | A-Award | Acquired | 1,642 | $0.00 |
| 10 Jun 2026 | HARRIGAN EDMUND | director | A-Award | Acquired | 6,111 | $100.64 |
| 10 Jun 2026 | Clancy Paul J | director | A-Award | Acquired | 1,642 | $0.00 |
| 10 Jun 2026 | Clancy Paul J | director | A-Award | Acquired | 6,111 | $100.64 |
| 10 Jun 2026 | FOUSE JACQUALYN A | director | A-Award | Acquired | 1,642 | $0.00 |
| 10 Jun 2026 | FOUSE JACQUALYN A | director | A-Award | Acquired | 6,111 | $100.64 |
| 10 Jun 2026 | BIENAIME JEAN JACQUES | director | A-Award | Acquired | 1,642 | $0.00 |
| Purchase |
| $1,001 - $15,000 |
| 5 Oct 2017 | Shelley Moore Capito | Shelley Moore Capito | Purchase | $1,001 - $15,000 |
| Disclosed | Representative | Office | Type | Amount |
|---|---|---|---|---|
| 2 Jun 2025 | Rob Bresnahan | Rob Bresnahan | Sale | $1,001 - $15,000 |
| 8 Oct 2024 | Ro Khanna | Ro Khanna | Sale | $1,001 - $15,000 |
| 5 Apr 2024 | Ro Khanna | Ro Khanna | Purchase | $1,001 - $15,000 |
| 8 Nov 2023 | Ro Khanna | Ro Khanna | Sale | $1,001 - $15,000 |
| 8 Nov 2023 | Ro Khanna | Ro Khanna | Sale | $1,001 - $15,000 |
| 6 Oct 2023 | Ro Khanna | Ro Khanna | Sale | $1,001 - $15,000 |
| 11 Jul 2023 | Ro Khanna | Ro Khanna | Purchase | $1,001 - $15,000 |
| 11 Jul 2023 | Ro Khanna | Ro Khanna | Purchase | $1,001 - $15,000 |
| 12 Jun 2023 | Ro Khanna | Ro Khanna | Purchase | $1,001 - $15,000 |
| 17 Apr 2023 | Daniel Goldman | Daniel Goldman | Sale | $1,001 - $15,000 |